Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Entrada Therapeutics, Inc. market cap for the quarter ending 2026-07-31 was $264.77M, a 18.68% increase year-over-year.
Entrada Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $286.96M, a 12.44% increase year-over-year.
Entrada Therapeutics, Inc. market cap for the quarter ending 2026-04-30 was $524.08M, a 51.24% increase year-over-year.
Entrada Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $490.5M, a 43.00% increase year-over-year.
Entrada Therapeutics, Inc. market cap for fiscal 2026 was $264.77M.
Entrada Therapeutics, Inc. market cap for fiscal 2025 was $393.56M, a 39.42% decline from fiscal 2024.
Entrada Therapeutics, Inc. market cap for fiscal 2024 was $649.66M, a 28.76% increase from fiscal 2023.
Entrada Therapeutics, Inc. market cap for fiscal 2023 was $504.57M, a 18.87% increase from fiscal 2022.